Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China: A national survey analysis-Reference-Cited by-同舟云学术

Status of transjugular intrahepatic portosystemic shunt for portal hypertension in China: A national survey analysis

Published:2023-03 Issue:1 Volume:2 Page:9-15
ISSN:2770-5838
Container-title:Portal Hypertension & Cirrhosis
language:en
Short-container-title:Portal Hypertension & Cirrhosis

Author:

Shao Haibo¹,Han Xinwei²,Zhao Jianbo³,Sun Junhui⁴,Fang Zhuting⁵,Xiong Bin⁶⁷,Zhu Xiaoli⁸,Ren Weixin⁹,Yuan Min¹⁰,Yu Shiping¹¹,Niu Meng¹,Lv Weifu¹²,Zhang Xueqiang¹³,Zhang Chunqing¹⁴,Li Lei¹⁵,Luo Xuefeng¹⁶,Song Yusheng¹⁷,Ma Yilong¹⁸,Dang Tong¹⁹,Xiang Hua²⁰,Jin Yun²¹,Xue Hui²²,Jin Guiyun²³,Li Xiao²⁴,Li Jiarui²⁵,Zhou Shi²⁶,Yu Changlu²⁷,He Song²⁸,Yu Lei²⁹,Zu Hongmei³⁰,Ma Jun³¹,Lei Yanming³²,Xu Ke¹,Qi Xiaolong³³^ORCID,

Affiliation:

1. Department of Interventional Therapy The First Hospital of China Medical University Shenyang Liaoning China

2. Department of Interventional Therapy The First Affiliated Hospital of Zhengzhou University Zhengzhou Henan China

3. Department of Interventional Therapy Nanfang Hospital, Southern Medical University/The First School of Clinical Medicine, Southern Medical University Guangzhou Guangdong China

4. Hepatobiliary and Pancreatic Intervention Center The First Affiliated Hospital, College of Medicine Zhejiang University Hangzhou Zhejiang China

5. Department of Interventional Therapy Fujian Provincial Hospital Fuzhou Fujian China

6. Department of Interventional Therapy, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China

7. Department of Interventional Therapy The First Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong China

8. Department of Interventional Therapy The First Affiliated Hospital of Suzhou University Suzhou Jiangsu China

9. Department of Interventional Therapy The First Affiliated Hospital of Xinjiang Medical University Wulumuqi Xinjiang China

10. Department of Interventional Therapy Shanghai Public Health Clinical Centre Affiliated to Fudan University Shanghai China

11. Department of Interventional Therapy Second Hospital of Shanxi Medical University Taiyuan Shanxi China

12. Department of Interventional Therapy The First Affiliated Hospital of USTC Hefei Anhui China

13. Department of Gastroenterology Second Hospital of HeBei Medical University Shijiazhuang Hebei China

14. Department of Gastroenterology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong China

15. Department of Interventional Therapy The First Hospital of Lanzhou University Lanzhou Gansu China

16. Department of Digestion West China Hospital of Sichuan University Chengdu Sichuan China

17. Department of Interventional Therapy Ganzhou People's Hospital Ganzhou Jiangxi China

18. Department of Interventional Therapy Guangxi Medical University Affiliated Tumor Hospital Oncology Medical College Nanning Guangxi China

19. Department of Gastroenterology The Second Affiliated Hospital of Baotou Medical College Baotou Nei Mongol China

20. Department of Interventional Therapy Hunan Provincial People's Hospital Changsha Hunan China

21. Department of Hepatobiliary Surgery The First People's Hospital of Yunnan Province Kunming Yunnan China

22. Department of Gastroenterology The First Affiliated Hospital of Xi'an Jiaotong University Xi'an Shaanxi China

23. Department of Interventional Therapy The First Affiliated Hospital of Hainan Medical College Haikou Hainan China

24. Department of Interventional Therapy, The Cancer Institute and Hospital Chinese Academy of Medical Sciences Beijing China

25. Department of Interventional Therapy The First Bethune Hospital of Jilin University Changchun Jilin China

26. Department of Interventional Therapy Affiliated Hospital of Guizhou Medical University Guiyang Guizhou China

27. Department of Radiology Tianjin Third Central Hospital Tianjin China

28. Department of Gastroenterology The Second Affiliated Hospital of Chongqing Medical University Chongqing China

29. Department of Infectious Diseases The Fourth Hospital of Harbin Medical University Harbin Heilongjiang China

30. Department of Hepatology The Fourth People's Hospital of Qinghai Province Xining Qinghai China

31. Department of Interventional Therapy People's Hospital of Ningxia Hui Autonomous Region Yinchuan Ningxia China

32. Department of Interventional Radiology Tibet Autonomous Region People's Hospital Lhasa Tibet China

33. Center for Portal Hypertension, Zhongda Hospital Southeast University Nanjing Jiangsu China

Abstract

AbstractAimThe transjugular intrahepatic portosystemic shunt (TIPS) procedure has been performed in China for 30 years, but our understanding of the status and difficulties associated with the use of TIPS for portal hypertension is incomplete. This study aims to investigate the current situation of the use of TIPS for portal hypertension, which should aid the development of TIPS in China.MethodsThis study involved a questionnaire survey, initiated by the China Portal Hypertension Alliance (CHESS) to investigate the use of TIPS for portal hypertension in China. Questionnaires were released on the Internet between August 16, 2022 and September 16, 2022. Detailed information was collected from 545 hospitals contracted by the CHESS in China, which performed TIPS surgery in 2021.ResultsThe 545 hospitals covers the majority of hospitals in China that conduct TIPS intervention. In the survey, a total of 13,527 TIPS interventions were carried out with 94.1% (498/545) of them had a system of routine follow‐up after TIPS. The majority (42.6% [232/545]) believed that the main indication of TIPS was the control of acute bleeding. Overall, 48.1% (262/545) carried out early or pre‐emptive TIPS, 53.0% (289/545) carried out TIPS for cavernous transformation of the portal vein, and 81.0% (441/545) chose routine embolization of collateral circulation during operation. Most used coils (97.0% [475/490]) and biological glue (72.0% [353/490]) as embolic materials, and 78.5% (428/545) routinely performed intraoperative portal pressure gradient measurements. When selecting TIPS stents, 57.1% (311/545) chose viator‐specific stents, and 57.2% (312/545) chose conventional anticoagulation after TIPS. Conventional anticoagulation after TIPS is over a time interval of 3–6 months (55.4% [173/312]). The limitation of TIPS surgery is mainly its cost (72.3% [394/545]) and insufficient understanding of the procedure by doctors in other related departments (77.4% [422/545]). Most of the hospital teams accept the use of domestic instruments in TIPS surgery (92.7% [505/545]).ConclusionsThis survey shows that TIPS is an essential part of the treatment of portal hypertension in China. TIPS is widely used in Chinese patients with portal hypertension, and this survey presents a more comprehensive picture of the options and difficulties encountered in the implementation of TIPS. In the future, it is necessary to promote TIPS technology and further standardize surgical indications, routine operations, and instrument application.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/poh2.40

Reference19 articles.

1. Baveno VII – Renewing consensus in portal hypertension

2. The global burden of liver disease: The major impact of China

3. Transjugular intrahepatic portal vein endoprosthetic shunt for portal hypertension in hepatic sclerosis (with analysis of eight cases) (in Chinese);Xu K;Chin J Radiol,1993

4. Thirty years' transjugular intrahepatic portosystemic stent‐shunt (TIPS) in China: Opportunities and challenges

5. CCI clinical practice guidelines: management of TIPS for portal hypertension (2019 edition) (in Chinese);Chinese College of Interventionalists;Chin J Hepatol,2019